|
US8071128B2
(en)
|
1996-06-14 |
2011-12-06 |
Kyowa Hakko Kirin Co., Ltd. |
Intrabuccally rapidly disintegrating tablet and a production method of the tablets
|
|
GB9720061D0
(en)
*
|
1997-09-19 |
1997-11-19 |
Crosfield Joseph & Sons |
Metal compounds as phosphate binders
|
|
US7815937B2
(en)
*
|
1998-10-27 |
2010-10-19 |
Biovail Laboratories International Srl |
Quick dissolve compositions and tablets based thereon
|
|
CA2348452A1
(en)
*
|
1998-10-27 |
2000-05-04 |
Biovail Technologies Ltd. |
Microparticles containing peg and/or peg glyceryl esters
|
|
CA2311734C
(en)
|
2000-04-12 |
2011-03-08 |
Bristol-Myers Squibb Company |
Flash-melt oral dosage formulation
|
|
US6733781B2
(en)
|
2000-12-06 |
2004-05-11 |
Wyeth |
Fast dissolving tablet
|
|
US7799342B2
(en)
|
2000-12-06 |
2010-09-21 |
Wyeth Llc |
Fast dissolving tablet
|
|
US20020122823A1
(en)
*
|
2000-12-29 |
2002-09-05 |
Bunick Frank J. |
Soft tablet containing dextrose monohydrate
|
|
US6814978B2
(en)
*
|
2000-12-29 |
2004-11-09 |
Mcneil-Ppc, Inc. |
Process for preparing a soft tablet
|
|
GB0113843D0
(en)
*
|
2001-06-07 |
2001-08-01 |
Boots Co Plc |
Therapeutic agents
|
|
US9358214B2
(en)
|
2001-10-04 |
2016-06-07 |
Adare Pharmaceuticals, Inc. |
Timed, sustained release systems for propranolol
|
|
FR2834890B1
(fr)
*
|
2002-01-23 |
2004-02-27 |
Servier Lab |
Composition pharmaceutique orodispersible d'agomelatine
|
|
FR2834896B1
(fr)
*
|
2002-01-23 |
2004-02-27 |
Servier Lab |
Composition pharmaceutique orodispersible d'ivabradine
|
|
FR2834893B1
(fr)
*
|
2002-01-23 |
2004-02-27 |
Servier Lab |
Composition pharmaceutique orodispersible de perindopril
|
|
GB0204771D0
(en)
*
|
2002-02-28 |
2002-04-17 |
Phoqus Ltd |
Fast disintegrating tablets
|
|
US20030190343A1
(en)
*
|
2002-03-05 |
2003-10-09 |
Pfizer Inc. |
Palatable pharmaceutical compositions for companion animals
|
|
US6753009B2
(en)
*
|
2002-03-13 |
2004-06-22 |
Mcneil-Ppc, Inc. |
Soft tablet containing high molecular weight polyethylene oxide
|
|
GB0209265D0
(en)
|
2002-04-23 |
2002-06-05 |
Novartis Ag |
Organic compounds
|
|
FR2838647B1
(fr)
*
|
2002-04-23 |
2006-02-17 |
|
Particules enrobees a liberation prolongee, leur procede de preparation et comprimes les contenant
|
|
FR2845914B1
(fr)
*
|
2002-10-18 |
2005-11-04 |
Schwarz Pharma Lab |
Compose antiemetique a desagregation rapide
|
|
JP2006509771A
(ja)
*
|
2002-11-25 |
2006-03-23 |
パーデュー・リサーチ・ファウンデイション |
マンノースをベースとした速溶性錠剤
|
|
US8367111B2
(en)
*
|
2002-12-31 |
2013-02-05 |
Aptalis Pharmatech, Inc. |
Extended release dosage forms of propranolol hydrochloride
|
|
ATE454132T1
(de)
*
|
2003-01-21 |
2010-01-15 |
Nippon Shinyaku Co Ltd |
Rasch in der mundhöhle schmelzende tablette
|
|
JP4739217B2
(ja)
*
|
2003-05-07 |
2011-08-03 |
サムヤン コーポレイション |
速く溶ける錠剤を製造するための高可塑性顆粒
|
|
US8263126B2
(en)
|
2003-06-06 |
2012-09-11 |
Ethypharm |
Orally-dispersible multilayer tablet
|
|
US20070071810A1
(en)
*
|
2003-08-26 |
2007-03-29 |
Kenichi Kudo |
Additive for tablets
|
|
US7282217B1
(en)
*
|
2003-08-29 |
2007-10-16 |
Kv Pharmaceutical Company |
Rapidly disintegrable tablets
|
|
PT3395338T
(pt)
|
2003-09-12 |
2019-07-23 |
Amgen Inc |
Formulação de dissolução rápida de cinacalcet hcl
|
|
DE10351448A1
(de)
*
|
2003-11-04 |
2005-06-09 |
Bayer Healthcare Ag |
Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
|
|
US20050181050A1
(en)
*
|
2004-01-28 |
2005-08-18 |
Collegium Pharmaceutical, Inc. |
Dosage forms using drug-loaded ion exchange resins
|
|
GB0408078D0
(en)
*
|
2004-04-08 |
2004-05-12 |
Novartis Ag |
Organic compounds
|
|
US20050244492A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Mehra Dev K |
Rapidly disintegrating tablets comprising titanium dioxide
|
|
US20070196477A1
(en)
*
|
2004-04-30 |
2007-08-23 |
Withiam Michael C |
Rapidly dissolving tablets comprising low surface area calcium phosphates
|
|
US20050244493A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Withiam Michael C |
Rapidly disintegrating tablets comprising calcium carbonate
|
|
US20070196474A1
(en)
*
|
2004-04-30 |
2007-08-23 |
Withiam Michael C |
Rapidly disintegrating low friability tablets comprising calcium carbonate
|
|
US20070196475A1
(en)
*
|
2004-04-30 |
2007-08-23 |
Withiam Michael C |
Rapidly disintegrating low friability tablets comprising silica materials
|
|
US20070196476A1
(en)
*
|
2004-04-30 |
2007-08-23 |
Withiam Michael C |
Rapidly dissolving tablets comprising low surface area titanium dioxide
|
|
US20050244343A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Withiam Michael C |
Oral care products comprising silica
|
|
US20050244347A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Mehra Dev K |
Oral care products comprising calcium phosphates
|
|
WO2005123045A2
(en)
*
|
2004-06-10 |
2005-12-29 |
Glatt Air Techniques, Inc. |
Controlled release matrix pharmaceutical dosage formulation
|
|
US8747895B2
(en)
|
2004-09-13 |
2014-06-10 |
Aptalis Pharmatech, Inc. |
Orally disintegrating tablets of atomoxetine
|
|
US9884014B2
(en)
|
2004-10-12 |
2018-02-06 |
Adare Pharmaceuticals, Inc. |
Taste-masked pharmaceutical compositions
|
|
NZ589750A
(en)
|
2004-10-21 |
2012-07-27 |
Aptalis Pharmatech Inc |
Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
|
|
US20060105038A1
(en)
*
|
2004-11-12 |
2006-05-18 |
Eurand Pharmaceuticals Limited |
Taste-masked pharmaceutical compositions prepared by coacervation
|
|
ITMI20042356A1
(it)
|
2004-12-10 |
2005-03-10 |
Acraf |
Composizione farmaceutica orodisperdibile e procedimento per prepararla
|
|
US20070036843A1
(en)
*
|
2005-01-28 |
2007-02-15 |
Collegium Pharmaceutical, Inc. |
Non-ionic non-aqueous vehicles for topical and oral administration of carrier-complexed active agents
|
|
WO2006085497A1
(ja)
*
|
2005-02-09 |
2006-08-17 |
Kissei Pharmaceutical Co., Ltd. |
口腔内崩壊錠
|
|
US9161918B2
(en)
|
2005-05-02 |
2015-10-20 |
Adare Pharmaceuticals, Inc. |
Timed, pulsatile release systems
|
|
GB0516604D0
(en)
*
|
2005-08-12 |
2005-09-21 |
Sandoz Ag |
Rapidly dispersing/disintegrating compositions
|
|
CA2620594C
(en)
*
|
2005-09-01 |
2012-08-21 |
Eisai R&D Management Co., Ltd. |
Pharmaceutical composition having improved disintegratability
|
|
WO2007031933A2
(en)
|
2005-09-12 |
2007-03-22 |
Actelion Pharmaceuticals Ltd |
Stable pharmaceutical composition comprising a pyrimidine-sulfamide
|
|
FR2891147B1
(fr)
|
2005-09-28 |
2007-12-07 |
Ethypharm Sa |
Comprimes orodispersibles de principes actifs amers
|
|
US20070092553A1
(en)
*
|
2005-10-21 |
2007-04-26 |
Pfab Lp |
Compositions and methods of making rapidly dissolving lonically masked formulations
|
|
US8497258B2
(en)
|
2005-11-12 |
2013-07-30 |
The Regents Of The University Of California |
Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
|
|
US20090030057A1
(en)
*
|
2005-11-22 |
2009-01-29 |
Shlomit Wizel |
Pharmaceutical composition of telmisartan
|
|
US20070116759A1
(en)
*
|
2005-11-22 |
2007-05-24 |
Gershon Kolatkar |
Pharmaceutical compositions of telmisartan
|
|
US20070141147A1
(en)
*
|
2005-12-21 |
2007-06-21 |
Auriga Laboratories, Inc. |
Sequential release pharmaceutical formulations
|
|
CN101410094B
(zh)
*
|
2006-01-27 |
2013-04-17 |
阿普塔利斯制药股份有限公司 |
包含弱碱性选择性5-羟色胺5-ht3阻断剂和有机酸的药物递送系统
|
|
KR20140088230A
(ko)
*
|
2006-01-27 |
2014-07-09 |
앱탈리스 파마테크, 인코포레이티드 |
약 염기성 약물과 유기산을 포함하는 약물 전달 시스템
|
|
MY157620A
(en)
|
2006-01-31 |
2016-06-30 |
Cytochroma Dev Inc |
A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
|
|
JP2009526040A
(ja)
*
|
2006-02-10 |
2009-07-16 |
エル・ジー ハウスホールド アンド ヘルスケア リミティッド |
同時溶解及びゲル化錠剤型の口腔衛生組成物
|
|
CN101522174A
(zh)
*
|
2006-05-10 |
2009-09-02 |
赢创德固赛有限责任公司 |
辊压热解制备的二氧化硅在药物组合物中的应用
|
|
JP2009536165A
(ja)
*
|
2006-05-10 |
2009-10-08 |
エボニック デグサ ゲーエムベーハー |
医薬組成物におけるロール圧縮された熱分解的に製造された二酸化ケイ素の使用
|
|
EP2043613A1
(de)
*
|
2006-07-14 |
2009-04-08 |
Fmc Corporation |
Feste form
|
|
NZ574544A
(en)
|
2006-08-04 |
2011-12-22 |
Ethypharm Sa |
Granule and orally disintegrating tablet comprising oxycodone
|
|
DK2046300T3
(da)
|
2006-08-04 |
2010-07-26 |
Ethypharm Sa |
Oralt desintegrerende multilagstablet
|
|
EP2050448A4
(de)
*
|
2006-08-08 |
2012-01-04 |
Kissei Pharmaceutical |
Im mund zerfallende tablette mit maskiertem bitterem geschmack und herstellungsverfahren dafür
|
|
WO2008018086A1
(en)
*
|
2006-08-10 |
2008-02-14 |
Bajaj Healthcare Limited |
Mouth dissolving pharmaceutical or nutraceutical composition
|
|
EP1897543A1
(de)
|
2006-08-30 |
2008-03-12 |
Euro-Celtique S.A. |
Buprenorphine-Waffel zur Substitutionstherapie
|
|
US20080064694A1
(en)
*
|
2006-09-11 |
2008-03-13 |
Auriga Laboratories, Inc. |
Multi-Phase Release Methscopolamine Compositions
|
|
US20080069874A1
(en)
*
|
2006-09-15 |
2008-03-20 |
Auriga Laboratories, Inc. |
Kits for Prevention and Treatment of Rhinitis
|
|
US20080085312A1
(en)
*
|
2006-10-04 |
2008-04-10 |
Auriga Laboratories, Inc. |
Multi-Phase Release Potassium Guaiacolsulfonate Compositions
|
|
US20080085310A1
(en)
*
|
2006-10-06 |
2008-04-10 |
Maria Oksana Bachynsky |
Capecitabine rapidly disintegrating tablets
|
|
EP2069062A2
(de)
*
|
2006-10-06 |
2009-06-17 |
The President and Fellows of Harvard College |
Chemisch gerichtete elektrostatische selbstanordnung von materialien
|
|
WO2008079342A2
(en)
*
|
2006-12-21 |
2008-07-03 |
Mallinckrodt Inc. |
Composition of and method for preparing orally disintegrating tablets
|
|
AU2007338751A1
(en)
*
|
2006-12-21 |
2008-07-03 |
Mallinckrodt Inc. |
Composition of and method for preparing orally disintegrating tablets containing a high dose of pharmaceutically active ingredients
|
|
EP2120945A1
(de)
*
|
2007-02-28 |
2009-11-25 |
Collegium Pharmaceutical, Inc. |
Antihistamin-kombination
|
|
US20080260823A1
(en)
*
|
2007-04-20 |
2008-10-23 |
Sciele Pharma, Inc. |
Orally disintegrating tablet comprising glycopyrrolate for treating sialorrhea
|
|
US8309129B2
(en)
|
2007-05-03 |
2012-11-13 |
Bend Research, Inc. |
Nanoparticles comprising a drug, ethylcellulose, and a bile salt
|
|
US8703204B2
(en)
|
2007-05-03 |
2014-04-22 |
Bend Research, Inc. |
Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and anon-ionizable polymer
|
|
US20080311162A1
(en)
*
|
2007-05-16 |
2008-12-18 |
Olivia Darmuzey |
Solid form
|
|
WO2008149230A2
(en)
|
2007-06-04 |
2008-12-11 |
Pfizer Products Inc. |
Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glycol succinate
|
|
EP2162120B1
(de)
|
2007-06-04 |
2016-05-04 |
Bend Research, Inc |
Nanopartikel mit nicht ionisierbarem zellulosepolymer und amphipilem nicht ionisierbarem blockcopolymer
|
|
GB0714670D0
(en)
*
|
2007-07-27 |
2007-09-05 |
Ineos Healthcare Ltd |
Use
|
|
EP2205213A2
(de)
|
2007-10-01 |
2010-07-14 |
Laboratorios Lesvi, S.L. |
Im mund dispergierbare tabletten
|
|
GB0720220D0
(en)
|
2007-10-16 |
2007-11-28 |
Ineos Healthcare Ltd |
Compound
|
|
BRPI0819231B8
(pt)
*
|
2007-10-31 |
2021-05-25 |
Mcneil Ppc Inc |
processo para preparo de forma farmacêutica de desintegração rápida por moldagem a quente na presença de sal inorgânico hidratado
|
|
CN101868228B
(zh)
*
|
2007-11-21 |
2016-12-07 |
大日本住友制药株式会社 |
口腔内崩解片
|
|
EP2231169B1
(de)
|
2007-12-06 |
2016-05-04 |
Bend Research, Inc. |
Pharmazeutische zusammensetzungen mit nanopartikeln und resuspensionsmaterial
|
|
WO2009073216A1
(en)
|
2007-12-06 |
2009-06-11 |
Bend Research, Inc. |
Nanoparticles comprising a non-ionizable polymer and an amine-functionalized methacrylate copolymer
|
|
US8133506B2
(en)
*
|
2008-03-12 |
2012-03-13 |
Aptalis Pharmatech, Inc. |
Drug delivery systems comprising weakly basic drugs and organic acids
|
|
JP5575119B2
(ja)
*
|
2009-05-20 |
2014-08-20 |
大日本住友製薬株式会社 |
口腔内崩壊錠
|
|
CN102458475B
(zh)
*
|
2009-05-20 |
2016-03-30 |
大日本住友制药株式会社 |
压制包衣的口腔崩解片
|
|
WO2010144865A2
(en)
|
2009-06-12 |
2010-12-16 |
Meritage Pharma, Inc. |
Methods for treating gastrointestinal disorders
|
|
US20110003005A1
(en)
*
|
2009-07-06 |
2011-01-06 |
Gopi Venkatesh |
Methods of Treating PDNV and PONV with Extended Release Ondansetron Compositions
|
|
GB0913525D0
(en)
|
2009-08-03 |
2009-09-16 |
Ineos Healthcare Ltd |
Method
|
|
US8475832B2
(en)
|
2009-08-07 |
2013-07-02 |
Rb Pharmaceuticals Limited |
Sublingual and buccal film compositions
|
|
US8313768B2
(en)
|
2009-09-24 |
2012-11-20 |
Mcneil-Ppc, Inc. |
Manufacture of tablet having immediate release region and sustained release region
|
|
US8784781B2
(en)
|
2009-09-24 |
2014-07-22 |
Mcneil-Ppc, Inc. |
Manufacture of chewing gum product with radiofrequency
|
|
US8858210B2
(en)
|
2009-09-24 |
2014-10-14 |
Mcneil-Ppc, Inc. |
Manufacture of variable density dosage forms utilizing radiofrequency energy
|
|
MX364947B
(es)
|
2009-10-01 |
2019-05-15 |
Adare Pharmaceuticals Inc |
Composiciones de corticosteroides administradas oralmente.
|
|
CN102958515A
(zh)
|
2009-12-02 |
2013-03-06 |
阿普塔利斯制药有限公司 |
非索非那定微胶囊及含有非索非那定微胶囊的组合物
|
|
US20110150993A1
(en)
*
|
2009-12-22 |
2011-06-23 |
Fmc Corporation |
Fine Particle Croscarmellose and Uses Thereof
|
|
US20110212171A1
(en)
*
|
2010-01-08 |
2011-09-01 |
Eurand, Inc. |
Taste masked topiramate composition and an orally disintegrating tablet comprising the same
|
|
GB201001779D0
(en)
|
2010-02-04 |
2010-03-24 |
Ineos Healthcare Ltd |
Composition
|
|
EP2377522B1
(de)
*
|
2010-04-15 |
2013-01-16 |
Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi |
Formulierungen von im Mund zerfallenden Mirtazapintabletten und Herstellungsverfahren dafür.
|
|
US8722636B2
(en)
|
2011-01-31 |
2014-05-13 |
New Market Pharmaceuticals, LLC |
Animal treatments
|
|
CN103402519B
(zh)
|
2011-04-18 |
2015-11-25 |
卫材R&D管理有限公司 |
肿瘤治疗剂
|
|
WO2012156981A1
(en)
*
|
2011-05-13 |
2012-11-22 |
Cadila Healthcare Limited |
Pharmaceutical compositions of lurasidone
|
|
MX353289B
(es)
*
|
2011-05-25 |
2018-01-05 |
Taiho Pharmaceutical Co Ltd |
Tableta revestida en seco que contiene tegafur, gimeracil y oteracil potasico.
|
|
JP6038128B2
(ja)
|
2011-06-03 |
2016-12-07 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
レンバチニブ化合物に対する甲状腺癌対象及び腎臓癌対象の反応性を予測及び評価するためのバイオマーカー
|
|
JP6245677B2
(ja)
*
|
2012-01-20 |
2017-12-13 |
ニプロ株式会社 |
口腔内崩壊錠
|
|
US9744134B2
(en)
|
2012-02-03 |
2017-08-29 |
Asahi Kasei Chemicals Corporation |
Orally disintegrating tablet containing bitterness-masking granules
|
|
US9511028B2
(en)
|
2012-05-01 |
2016-12-06 |
Johnson & Johnson Consumer Inc. |
Orally disintegrating tablet
|
|
US9445971B2
(en)
|
2012-05-01 |
2016-09-20 |
Johnson & Johnson Consumer Inc. |
Method of manufacturing solid dosage form
|
|
ES3034104T3
(en)
|
2012-05-02 |
2025-08-13 |
Newmarket Pharmaceuticals Llc |
Pharmaceutical compositions for direct systemic introduction
|
|
IN2014DN10072A
(de)
|
2012-05-31 |
2015-08-14 |
Asahi Kasei Chemicals Corp |
|
|
KR20150098605A
(ko)
|
2012-12-21 |
2015-08-28 |
에자이 알앤드디 매니지먼트 가부시키가이샤 |
퀴놀린 유도체의 비정질 형태 및 그의 제조방법
|
|
ITMI20130210A1
(it)
*
|
2013-02-14 |
2014-08-15 |
Menarini Lab |
Composizioni farmaceutiche contenenti dexketoprofene e tramadolo
|
|
GB201303781D0
(en)
*
|
2013-03-04 |
2013-04-17 |
Gauthier Pierre Pascal |
Oral timer device and method of using same
|
|
NZ714049A
(en)
|
2013-05-14 |
2020-05-29 |
Eisai R&D Man Co Ltd |
Biomarkers for predicting and assessing responsiveness of endometrial cancer subjects to lenvatinib compounds
|
|
WO2015034678A2
(en)
|
2013-09-06 |
2015-03-12 |
Aptalis Pharmatech, Inc. |
Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
|
|
BR112016015944A8
(pt)
|
2014-01-10 |
2020-06-09 |
Johnson & Johnson Consumer Inc |
processo para produzir comprimido, que usa radiofrequência e partículas revestidas dissipadoras de energia
|
|
PT3524595T
(pt)
|
2014-08-28 |
2022-09-19 |
Eisai R&D Man Co Ltd |
Derivado de quinolina altamente puro e método para produção do mesmo
|
|
LT3263106T
(lt)
|
2015-02-25 |
2024-01-10 |
Eisai R&D Management Co., Ltd. |
Chinolino darinių kartumo sumažinimo būdas
|
|
KR102662228B1
(ko)
|
2015-03-04 |
2024-05-02 |
머크 샤프 앤드 돔 코포레이션 |
암을 치료하기 위한 pd-1 길항제 및 vegfr/fgfr/ret 티로신 키나제 억제제의 조합
|
|
MX373231B
(es)
|
2015-06-16 |
2020-05-08 |
Eisai R&D Man Co Ltd |
Agente anticancerigeno.
|
|
US12220398B2
(en)
|
2015-08-20 |
2025-02-11 |
Eisai R&D Management Co., Ltd. |
Tumor therapeutic agent
|
|
US20170172880A1
(en)
*
|
2015-12-18 |
2017-06-22 |
Colgate-Palmolive Company |
Fast Dissolving Peroxymonosulfate Composition
|
|
CN108601957B
(zh)
|
2015-12-23 |
2021-12-10 |
高露洁-棕榄公司 |
储存稳定的固体过一硫酸盐组合物
|
|
EP3484588B1
(de)
|
2016-08-11 |
2023-07-26 |
Colgate-Palmolive Company |
Peroxymonosulfatzahnpulverzusammensetzung für hartnäckige flecken
|
|
TWI728172B
(zh)
|
2016-08-18 |
2021-05-21 |
美商愛戴爾製藥股份有限公司 |
治療嗜伊紅性食道炎之方法
|
|
US12303505B2
(en)
|
2017-02-08 |
2025-05-20 |
Eisai R&D Management Co., Ltd. |
Tumor-treating pharmaceutical composition
|
|
US10493026B2
(en)
|
2017-03-20 |
2019-12-03 |
Johnson & Johnson Consumer Inc. |
Process for making tablet using radiofrequency and lossy coated particles
|
|
RU2019134940A
(ru)
|
2017-05-16 |
2021-06-16 |
Эйсай Ар Энд Ди Менеджмент Ко., Лтд. |
Лечение гепатоцеллюлярной карциномы
|
|
WO2020020999A1
(en)
*
|
2018-07-27 |
2020-01-30 |
Sandoz Ag |
Process for preparing rapidly or very rapidly dissolving tablets comprising freely soluble api
|
|
CN116829122B
(zh)
|
2021-01-25 |
2026-03-17 |
高露洁-棕榄公司 |
包含pvp和hec作为粘合剂体系的固体口腔护理组合物
|
|
CA3206909A1
(en)
|
2021-02-19 |
2022-08-25 |
Cajetan DOGO-ISONAGIE |
Peroxymonosulfate whitening strips
|
|
US20220339082A1
(en)
|
2021-04-23 |
2022-10-27 |
Colgate-Palmolive Company |
Solid Oral Care Compositions
|